Depression is one of the most common comorbidities of chronic diseases including diabetes and obstructive lung diseases (emphysema, chronic bronchitis, and asthma). Obstructive lung diseases and depression have few symptoms in common. However, they are both common in adults and associated with chronic inflammation. It is not clear if their coappearance in diabetic patients is coincidental or associated beyond that expected by chance.

Age-related macular degeneration (AMD) is a common and potentially devastating eye disease affecting millions of people worldwide. Among the two major subtypes of AMD, the wet form poses a significant threat to vision due to the development of choroidal neovascularization and subsequent retinal damage. Anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionized the treatment landscape for wet AMD, particularly with the advent of ranibizumab, a widely used monoclonal antibody targeting VEGF-A. The incidence of wet AMD has been steadily increasing with the ageing population, leading to a growing public health concern. Early diagnosis and prompt initiation of effective treatment are critical to preserving vision and preventing disease progression. The introduction of anti-VEGF agents, particularly ranibizumab, has significantly improved visual outcomes for many patients, leading to a reduction in severe visual loss and stabilizing or even improvement in visual acuity.

Unusual presentations of disease states that have been well characterized over the years is key to ensuring the safety of patients and decreasing the overall mortality and morbidity. Patients often present with variations on classical conditions and it is key that providers be able to recognize these variations. This case study presents a 70-year-old female with a complex past medical history with variation of the classical Hakim-Adams triad of Normal Pressure Hydrocephalus.

Anorexia nervosa (AN) is a serious psychiatric illness that carries at least a four-fold increased risk of death versus aged-matched controls. However, women with AN and concurrent depression are eight times more likely to die compared to the general population and 24 times more likely to die from unnatural causes 

Repetitive transcranial magnetic stimulation (rTMS) has appeared as a new non-invasive antidepressant method, which implies non-convulsive focal stimulation of the brain through a time-varying magnetic field. Research indicates, that rTMS of the prefrontal cortex has a significant antidepressant effect and is associated with minimal side effects. An increasing number of scientific original works and meta-analyses have in recent years substantiated the evidence of the antidepressant effect of the method, and rTMS is today approved for the treatment of depression in an increasing number of countries all over the world.